Background/Objectives: Head and neck squamous cell carcinoma (HNSCC) diagnosis and treatment rely heavily on computed tomography (CT) imaging to evaluate tumor characteristics and lymph node (LN) involvement, crucial for staging, prognosis, and therapy planning. Conventional LN evaluation methods based on morphological criteria such as size, shape, and anatomical location often lack sensitivity for early metastasis detection. This study leverages radiomics to extract quantitative features from CT images, addressing the limitations of subjective assessment and aiming to enhance LN classification accuracy while potentially reducing reliance on invasive histopathology. Methods: We analyzed 234 LNs from 27 HNSCC patients, deriving 120 features per node, resulting in over 25,000 data points classified into reactive, pathologic, and pathologic with extracapsular spread classes. Considering the challenges of high dimensionality and limited dataset size, more than 44,000 experiments systematically optimized machine learning models, feature selection methods, and hyperparameters, including ensemble approaches to strengthen classification robustness. A Pareto front strategy was employed to balance diagnostic accuracy with significant feature reduction. Results: The optimal model, validated via 5-fold cross-validation, achieved a balanced accuracy of 0.90, an area under the curve (AUC) of 0.93, and an F1-score of 0.88 using only five radiomics features. Conclusions: This interpretable approach aligns well with clinical radiology practice, demonstrating strong potential for clinical application in noninvasive LN classification in HNSCC.
Background: Distinguishing vital from non-vital persistent cervical lymph nodes after chemoradiotherapy in HNSCC remains clinically challenging. We investigated whether image-level data augmentation improves CT-based radiomics classification for this task. Methods: We evaluated eight augmentation strategies and their 28 pairwise combinations in 55 patients, using Bayesian hyperparameter tuning with Optuna for parameter optimization. A radiomics pipeline comprising Radiomics features, five feature selectors, and seven classifiers was assessed using patient-level stratified 5-fold cross-validation. Configurations were ranked using a composite score defined as the mean of AUC, ACC and F1-score. Results: Feature selection improved the composite score from 0.659 to 0.742. The best augmented configuration, Window Contrast Variation, achieved a composite score of 0.803 and an AUC of 0.831, corresponding to an 8.2% relative point-estimate gain over feature selection alone and a 21.9% gain over the no-selection baseline when feature selection and augmentation were combined. Conclusions: These findings suggest that feature selection with optimized augmentation may enhance radiomics-based lymph node classification. However, individual augmentation-versus-baseline differences did not reach statistical significance in this limited sample, requiring confirmation in larger cohorts.